Skip to main content
OpenTrials

Clinical trial condition

Hyperlipoproteinemia Type II

Explore clinical trials studying Hyperlipoproteinemia Type II. Study availability and eligibility vary by location and protocol.

39 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Hyperlipoproteinemia Type II trial results

Completed

Efficacy and Safety of Lomitapide in Paediatric Patients With Homozygous Familial Hypercholesterolaemia (HoFH)

NCT04681170

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations
  • Universtiats-Kinderlinik Heidelberg Heidelberg, Baden-Wurttemberg, Germany
  • University Hospital of Cologne Cologne, Germany
  • University Medical Center Hamburg-Eppendorf Hamburg, Germany
  • Chaim Sheba Medical Center Ramat Gan, Israel
View Trial Details
Completed

Evaluate the Long-Term Safety and Efficacy of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia

NCT03409744

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Clinical Trial Site Los Angeles, California, United States
  • Clinical Trial Site Boca Raton, Florida, United States
  • Clinical Trial Site Boston, Massachusetts, United States
  • Clinical Trial Site New York, United States
View all 38 locations
View Trial Details
Completed

Evaluate the Efficacy and Safety of Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia

NCT04233918

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Regeneron Research Site Wilmington, Delaware, United States
  • Regeneron Research Site Boca Raton, Florida, United States
  • Regeneron Research Site Kansas City, Kansas, United States
  • Regeneron Research Center Boston, Massachusetts, United States
View Trial Details
Completed

Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C

NCT03814187

Conditions
ASCVD, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, +13 more
Locations
  • Research Site 10001-015 Birmingham, Alabama, United States
  • Research Site 10001-138 Foley, Alabama, United States
  • Research Site 10001-113 Huntsville, Alabama, United States
  • Research Site 10001-058 Mobile, Alabama, United States
View all 238 locations
View Trial Details
Completed

Phase 3 Study to Evaluate the Efficacy and Safety of LIB003 With Evolocumab in HoFH

NCT04034485

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • NorthShore University Health System Evanston, Illinois, United States
  • Metabolic & Atherosclerosis Research Center (MARC) Cincinnati, Ohio, United States
  • VMMC & Safdarjung Hospital Delhi, National Capital Territory of Delhi, India
  • CIMS Hospital Pvt. Ltd Ahmedabad, India
View Trial Details

Related conditions